机器人辅助子宫转位后解剖性盆腔复位用于壁内子宫肌瘤合并直肠癌患者
一例36岁新诊断cT3N2M0直肠腺癌女性,因需盆腔放疗而要求保留生育功能,在促排卵和取卵后2周行机器人辅助子宫-卵巢整块转位至上腹部,术中静脉注射吲哚菁绿评估子宫灌注;术后3周因小肠梗阻行腹腔镜粘连松解术,完成放化疗后直肠肿瘤达完全缓解,转位后7个月行机器人辅助子宫-卵巢解剖性盆腔复位及宫颈阴道吻合术,术后4个月宫颈阴道外观正常,患者恢复自然月经和无并发症的性生活。
要点
- 机器人辅助子宫-卵巢转位可为需盆腔放疗的直肠癌患者保留生育功能。
- 壁内子宫肌瘤的存在不应单独作为排除子宫-卵巢转位的依据。
- 该技术可能适用于部分希望放疗后妊娠的癌症患者。
核心结论
- 本病例因存在较大的壁内子宫肌瘤而具有独特性,所描述的技术可能适用于部分希望盆腔放疗后妊娠的癌症患者,并表明考虑子宫-卵巢转位的患者不应仅因存在子宫肌瘤而被排除。
研究设计与样本
- 技术描述与手术录像展示,场景为大学医院,患者为1例36岁新诊断cT3N2M0直肠腺癌女性。
主要发现
- 经阴道超声显示5 cm后壁平滑肌瘤和正常子宫内膜腔,患者选择在放化疗前接受子宫-卵巢转位。
- 在促排卵和取卵后2周于住院条件下行机器人辅助子宫-卵巢转位,取卵后给予促性腺激素释放激素激动剂抑制月经。
- 子宫和附件整块转位至上腹部,通过反折的骨盆漏斗韧带供血,术中静脉给予吲哚菁绿以观察子宫灌注。
- 术后3周因小肠梗阻行腹腔镜粘连松解术成功处理,随后完成放化疗且直肠肿瘤达完全缓解,患者选择监测。
- 转位后7个月、治疗完成后2个月行机器人辅助子宫-卵巢解剖性盆腔复位及宫颈阴道吻合术,色素输卵管通液确认输卵管通畅。
关键数值与推荐
- 术后4个月随访时宫颈和阴道外观正常,患者报告自然月经恢复且性生活无并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report the first described case of robotic-assisted utero-ovarian transposition followed by anatomic repositioning in the pelvis and cervicovaginal anastomosis in a woman with uterine fibroids, which was performed for fertility preservation in the context of pelvic radiation for rectal cancer. DESIGN: Description of technique and live-action narrated surgical footage showing uterine transposition and repositioning. SETTING: University hospital. PATIENTS: A 36-year-old woman with a new diagnosis of cT3N2M0 rectal adenocarcinoma planned for neoadjuvant chemotherapy and pelvic radiation and desired fertility preservation permissive of future pregnancy. A transvaginal ultrasound revealed a 5-cm posterior leiomyoma and a normal endometrial cavity. The patient elected for utero-ovarian transposition before chemoradiation. The patient included in this video gave consent for publication and posting of the video online, including on social media, the journal website, scientific literature websites, and other applicable sites. Per institutional guidelines, an Institutional Review Board review was not required. INTERVENTIONS: Robotic-assisted utero-ovarian transposition was performed in an inpatient setting 2 weeks after ovarian stimulation and oocyte retrieval. She was given a gonadotropin-releasing hormone agonist for menstrual suppression after oocyte retrieval. The uterus and adnexa were transposed en bloc to the upper abdomen, with perfusion via retroflected infundibulopelvic ligaments. Intravenous indocyanine green was administered intraoperatively to visualize uterine perfusion. Three weeks postoperatively, the patient underwent surgical management of small bowel obstruction, which was successfully managed with laparoscopic adhesiolysis. The patient subsequently completed chemoradiation and had a complete response to the rectal tumor. She therefore elected for surveillance. Seven months after transposition and 2 months after completion of treatment, the patient underwent uncomplicated robotic-assisted utero-ovarian anatomic repositioning in the pelvis with cervicovaginal anastomosis. Chromopertubation confirmed tubal patency. MAIN OUTCOME MEASURES: Restoration of normal pelvic anatomy and resumption of reproductive physiology. RESULTS: At her 4-month postoperative visit, the cervix and vagina were normal in appearance. The patient reported the return of spontaneous menses and sexual activity without complications. CONCLUSION: This case is unique because of the presence of bulky intramural uterine fibroids. The described technique may be useful for selected cancer patients who desire to carry a pregnancy after pelvic radiation for cancer treatment, and demonstrates that patients considering utero-ovarian transposition need not be excluded solely on the basis of the presence of uterine fibroids.
引用
- Gornet ME, Christianson MS, Stone RL, et al. Robotic-assisted uterine transposition followed by anatomic pelvic repositioning for a patient with intramural fibroids and rectal cancer. Fertil Steril. 2024. PMID: 38522504. doi:10.1016/j.fertnstert.2024.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。